Compounds > elliptinium
Page last updated: 2024-08-23

elliptinium and Adenocarcinoma

elliptinium has been researched along with Adenocarcinoma in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19904 (80.00)18.7374
1990's1 (20.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amiel, JL; Bidart, M; Caille, P; Droz, JP; Ducret, JP; Garnier, HS; Le Chevalier, T; Rouessé, J; Théodore, C; Travagli, JP1
Atassi, G; Bisagni, E; Burbridge, M; Guilbaud, N; Jan, M; Kraus-Berthier, L; Pierré, A; Rouillon, MH; Saint-Dizier, D; Visalli, M1
Anderson, G; Clavel, M; Dalesio, O; Giaccone, G; Gracia, M; Kirkpatrick, A; McVie, G; Planting, AS; Smyth, J1
Byrne, PJ; Greenspan, A; McCabe, MS; Rahman, A; Treat, J1
Blanc, AP; Garrigues, B; Pedinielli, FJ; Routy, JP1

Other Studies

5 other study(ies) available for elliptinium and Adenocarcinoma

ArticleYear
[Treatment of metastatic renal cancer in adults with elliptinium acetate].
    Presse medicale (Paris, France : 1983), 1984, Jun-16, Volume: 13, Issue:25

    Topics: Adenocarcinoma; Adult; Aged; Alkaloids; Antineoplastic Agents; Ellipticines; Female; Humans; Kidney Neoplasms; Male; Middle Aged; Neoplasm Metastasis

1984
In vivo antitumor activity of S 16020-2, a new olivacine derivative.
    Cancer chemotherapy and pharmacology, 1996, Volume: 38, Issue:6

    Topics: Adenocarcinoma; Administration, Oral; Animals; Antineoplastic Agents; Blood Cell Count; Bone Marrow; Breast Neoplasms; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; Doxorubicin; Drug Administration Schedule; Drug Resistance, Neoplasm; Ellipticines; Female; Humans; Injections, Intraperitoneal; Injections, Intravenous; Leukemia P388; Lung Neoplasms; Lymphoma, Large B-Cell, Diffuse; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Neoplasm Transplantation; Neoplasms, Experimental; Tumor Cells, Cultured

1996
Phase II study of 9-hydroxy-2-methyl-ellipticinium acetate (ellipticinium) in patients with advanced carcinoma of the lung. EORTC Lung Cancer Cooperative Group.
    European journal of cancer & clinical oncology, 1989, Volume: 25, Issue:5

    Topics: Adenocarcinoma; Aged; Alkaloids; Antineoplastic Agents; Carcinoma; Drug Evaluation; Ellipticines; Female; Humans; Intercalating Agents; Lung Neoplasms; Male; Middle Aged

1989
Elliptinium: phase II study in advanced measurable breast cancer.
    Investigational new drugs, 1989, Volume: 7, Issue:2-3

    Topics: Adenocarcinoma; Adult; Aged; Alkaloids; Antineoplastic Agents; Breast Neoplasms; Drug Evaluation; Ellipticines; Female; Humans; Middle Aged; Neoplasm Metastasis

1989
[Fatal complication during treatment with elliptinium acetate].
    Presse medicale (Paris, France : 1983), 1985, Jan-19, Volume: 14, Issue:2

    Topics: Adenocarcinoma; Alkaloids; Antineoplastic Agents; Bone Neoplasms; Ellipticines; Female; Hematologic Diseases; Humans; Middle Aged

1985